http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2336884-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee601e97f2d938113c7940cf56a7887 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 |
| filingDate | 2007-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9544a64368e288ac7aed4dbf6bf733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b630d2b821801143f9e9f6ea381c8a05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8810827217e83a68a0017440f08496ff |
| publicationDate | 2008-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2336884-C1 |
| titleOfInvention | Optimization technique for venter endometriosis treatment in clinical trial |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, to gynecology in particular. It is designated for optimization of venter metriosis patients treatments in clinical trial. For this purpose patients of the reproductive age intake "Skvaakan" in addition to a hormonal medicine. The intake is implemented intramuscularly, 2.0 ml per day during 75 days with septan interruption after each 30 days. This method contributes to reduction of treatment terms, disease backsets, reactivation of reproductive function among the patients of this category. n EFFECT: reduction of treatment terms, disease backsets, reactivation of reproductive function. n 3 cl, 2 tbl, 2 ex |
| priorityDate | 2007-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.